206 related articles for article (PubMed ID: 11899853)
1. [The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis].
Lebensztejn DM
Pol Merkur Lekarski; 2001 Dec; 11(66):522-5. PubMed ID: 11899853
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
Kozłowska J; Łoch T; Jabłońska J; Cianciara J
Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological study on liver fibrosis in viral hepatitis].
Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
[TBL] [Abstract][Full Text] [Related]
4. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.
Michalak S; Rousselet MC; Bedossa P; Pilette C; Chappard D; Oberti F; Gallois Y; Calès P
J Pathol; 2003 Sep; 201(1):55-62. PubMed ID: 12950017
[TBL] [Abstract][Full Text] [Related]
5. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
Castera L
J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
[TBL] [Abstract][Full Text] [Related]
8. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
9. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
Bedossa P
Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
[TBL] [Abstract][Full Text] [Related]
10. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
Islam S; Antonsson L; Westin J; Lagging M
Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive biochemical markers of liver fibrosis.
Grigorescu M
J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
[TBL] [Abstract][Full Text] [Related]
13. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis and chronic viral hepatitis.
Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
[TBL] [Abstract][Full Text] [Related]
15. [Noninvasive estimation of fibrosis in chronic viral hepatitis].
Risum M; Barfod TS; Lindhardt BØ
Ugeskr Laeger; 2013 Aug; 175(34):1877-82. PubMed ID: 23952982
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
Huang W; Gong FY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
[TBL] [Abstract][Full Text] [Related]
17. [Assessment and reversibility of liver fibrosis in viral hepatitis].
Vallet-Pichard A; Pol S; Mallet V
Rev Prat; 2011 Jan; 61(1):39-43. PubMed ID: 21452541
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
20. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
